These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 26276675)

  • 1. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease.
    Lee KC; Lin HC; Huang YH; Hung SC
    J Hepatol; 2015 Dec; 63(6):1405-12. PubMed ID: 26276675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic efficacy of bone marrow-derived mesenchymal stem cells infused into mice with liver injury induced by concanavalin A].
    Ma J; Cao Y; Hu JL; Sun H; Liu LX; Zhao CH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1289-93. PubMed ID: 19840469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
    Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
    Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury.
    Ryu KH; Kim SY; Kim YR; Woo SY; Sung SH; Kim HS; Jung SC; Jo I; Park JW
    Exp Cell Res; 2014 Aug; 326(1):143-54. PubMed ID: 24954408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression.
    Liu Q; Chen X; Liu C; Pan L; Kang X; Li Y; Du C; Dong S; Xiang AP; Xu Y; Zhang Q
    Cell Death Dis; 2021 Mar; 12(3):240. PubMed ID: 33664231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cell-Derived Interleukin 1 Receptor Antagonist Promotes Macrophage Polarization and Inhibits B Cell Differentiation.
    Luz-Crawford P; Djouad F; Toupet K; Bony C; Franquesa M; Hoogduijn MJ; Jorgensen C; Noël D
    Stem Cells; 2016 Feb; 34(2):483-92. PubMed ID: 26661518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
    Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.
    Lafdil F; Wang H; Park O; Zhang W; Moritoki Y; Yin S; Fu XY; Gershwin ME; Lian ZX; Gao B
    Gastroenterology; 2009 Dec; 137(6):2125-35.e1-2. PubMed ID: 19686746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
    Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
    J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level.
    Wang W; Guo H; Li H; Yan Y; Wu C; Wang X; He X; Zhao N
    Hum Gene Ther; 2018 Feb; 29(2):234-241. PubMed ID: 29054137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A.
    Kubo N; Narumi S; Kijima H; Mizukami H; Yagihashi S; Hakamada K; Nakane A
    J Gastroenterol Hepatol; 2012 Jan; 27(1):165-72. PubMed ID: 21649723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis.
    Lee WY; Salmi M; Kelly MM; Jalkanen S; Kubes P
    Hepatology; 2013 Oct; 58(4):1413-23. PubMed ID: 23686782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
    J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse bone marrow-derived mesenchymal stem cells induce macrophage M2 polarization through the nuclear factor-κB and signal transducer and activator of transcription 3 pathways.
    Gao S; Mao F; Zhang B; Zhang L; Zhang X; Wang M; Yan Y; Yang T; Zhang J; Zhu W; Qian H; Xu W
    Exp Biol Med (Maywood); 2014 Mar; 239(3):366-75. PubMed ID: 24500984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Define Mesenchymal Stem Cell from Its Fate: Biodisposition of Human Mesenchymal Stem Cells in Normal and Concanavalin A-Induced Liver Injury Mice.
    Han L; Ma C; Peng H; Wu Z; Xu H; Wu J; Zhang N; Jiang Q; Ma C; Huang R; Li H; Pan G
    J Pharmacol Exp Ther; 2021 Nov; 379(2):125-133. PubMed ID: 34373354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice.
    Kato J; Okamoto T; Motoyama H; Uchiyama R; Kirchhofer D; Van Rooijen N; Enomoto H; Nishiguchi S; Kawada N; Fujimoto J; Tsutsui H
    Hepatology; 2013 Jan; 57(1):362-72. PubMed ID: 22936459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells alleviate liver injury induced by chronic-binge ethanol feeding in mice via release of TSG6 and suppression of STAT3 activation.
    Wan YM; Li ZQ; Zhou Q; Liu C; Wang MJ; Wu HX; Mu YZ; He YF; Zhang Y; Wu XN; Li YH; Xu ZY; Wu HM; Xu Y; Yang JH; Wang XF
    Stem Cell Res Ther; 2020 Jan; 11(1):24. PubMed ID: 31931878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
    Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
    J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined mesenchymal stem cell transplantation and interleukin-1 receptor antagonism after partial hepatectomy.
    Sang JF; Shi XL; Han B; Huang X; Huang T; Ren HZ; Ding YT
    World J Gastroenterol; 2016 Apr; 22(16):4120-35. PubMed ID: 27122663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 facilitates con a-induced IFN-γ-- mediated immune hepatic injury.
    Tsai CC; Huang WC; Chen CL; Hsieh CY; Lin YS; Chen SH; Yang KC; Lin CF
    J Immunol; 2011 Oct; 187(7):3867-77. PubMed ID: 21873526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.